RePORT International Resources

This catalog provides a listing of each course, seminar series, and other training modalities offered by each TRAC that are open to the TB community. Just as a university or college course catalog is divided into the offerings provided by a given department, the TRAC Train catalog lists the virtual, hybrid, and in-person seminar series, journal clubs, classes/workshops, and other events that are offered by each TRAC.

A three-part online study club series, hosted by the Diagnostics Equity Consortium (DEC) and the Global TB Community Advisory Board (TB CAB), explores the evolving TB diagnostic landscape and strategies to expand testing coverage. Session one addresses the TB testing gap and emerging diagnostic tools. Session two focuses on optimizing national diagnostic networks and test distribution. Session three examines the impact and trade-offs of near- and point-of-care TB tests in expanding access.

Implementation research (IR) is important for designing strategies or solutions to overcome bottlenecks that prevent proven and innovative public health interventions from reaching the people who need them. This ensure that these interventions are used in a manner that results in the outcome for which they were intended. Such solutions include how to overcome barriers to adoption of drugs, diagnostics or preventive measures that improve health for people at risk of malaria, tuberculosis, NTDs or other infectious diseases. IR can help to ensure that health solutions reach the people who need them and are used in ways that generate intended results. This course is a step-by-step online training for public health researchers and decision-makers, disease control programme managers, academics and others that focuses on how to design and demonstrate robust IR projects to improve control of infectious diseases of poverty and generate better health outcomes.

TDR supports effective and innovative global health research, through strengthening the research capacity of disease-affected countries, and promoting the translation of evidence into interventions that reduce the burden of infectious diseases and build resilience in the most vulnerable populations

TDR's catalogue of online courses in implementation research (IR)

Can assess all the 13th IAS Conference on HIV Science at this website

The Antibacterial Resistance Leadership Group (ARLG) invites requests for industry collaboration from the ARLG in the form of advice, guidance, protocol design for drug, device, or diagnostic development. The ARLG develops, designs, implements, and manages a clinical research agenda to increase knowledge of antibacterial resistance (AR). The ARLG aims to advance research by building transformational trials that will change clinical practice and reduce the impact of antibacterial resistance and antimicrobial resistance through the following strategies: - Early clinical evaluation of new antibacterials; - Comparative effectiveness or efficacy trials; - Strategy trials to optimize currently licensed antibacterials (dose, duration, need for drug) to reduce the risk of resistance; - Clinical algorithm testing strategies; - Treatment-based prevention measures; - Diagnostics testing in the context of treatment trials, epidemiologic elements, or behavioral modification; - Effective infection control programs which include surveillance for resistant organisms, outbreak investigation, and antibiotic stewardship to prevent the development and spread of resistant organisms; - Novel facilities level activities to prevent the development of resistance.

In 1974, the US National Research Act was signed into law, there-by creating the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. One of the charges to the Commission was to identify the basic ethical principles that should underlie the conduct of biomedical and behavioral research involving human subjects and to develop guidelines which should be followed to assure that such research is conducted in accordance with those principles. In carrying out the above, the Commission was directed to consider: (i) the boundaries between biomedical and behavioral research and the accepted and routine practice of medicine, (ii) the role of assessment of risk-benefit criteria in the determination of the appropriateness of research involving human subjects, (iii) appropriate guidelines for the selection of human subjects for participation in such research and (iv) the nature and definition of informed consent in various research settings. The Belmont Report attempts to summarize the basic ethical principles identified by the Commission in the course of its deliberations.

This Crash Course video, The Deadliest Infectious Disease of All Time, explores the history, biology, and global impact of TB. From its ancient origins to its ongoing role as a leading cause of infectious death worldwide, the video examines how TB spreads, why it remains so deadly, and how social and political factors shape its burden. Engaging and informative, the episode highlights both scientific advances and enduring health inequities.

The 2025 Results Report is a snapshot of the partnerships' progress in the fight to end AIDS, TB and malaria during 2024.

The Global Health Network aims to strengthen health research in underserved areas by: Supporting and streamlining research where evidence is lacking. Promoting equity in participation and access to research benefits through open sharing of knowledge and data. Building sustainable, skilled research teams in low-resource settings capable of leading and competing globally.

New course - free and online - An Introduction and Practical Guide to Community Engagement and Involvement in Global Health Research

Good Clinical Laboratory Practice (GCLP) is a set of guidelines describing the application of those Good Laboratory Practice principles that are relevant to the analyses of samples from clinical trials while ensuring the purpose and objectives of the Good Clinical Practice principles are maintained. In so doing, the reliability, quality, consistency and integrity of data generated by clinical trial laboratories can be assure which is crucial to the outcome of any clinical trial.

This ICH E6 GCP Investigator Site Training, in multiple languages, meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate BioPharma as necessary to enable mutual recognition of GCP training among trial sponsors.

Date & time: 21 October 2025 | 10:00–14:00 UTC+1 This comprehensive workshop aims to provide participants with the skills, strategies, and insights needed to navigate the 2025–2026 funding landscape confidently. Expert-led sessions will cover key aspects of grant funding, from identifying opportunities to understanding what funders look for, plus a Q&A session. Whether you're new to grant writing or refining your approach, you'll learn how to find funders, align your project with their priorities, set clear objectives, build realistic budgets, and write effectively. The workshop will also cover collaborative proposals and community engagement. This workshop is organised by The Global Health Network for the Pathogen Variants Network, a global collaboration of six research teams funded by Wellcome to work on SARS-CoV-2. It is open to all for wider benefit and impact.

New course - free and online - Research Ethics Online Training (V2)

The templates have been shared by groups, and are free to use and adapt for individual's research studies.

Date & time: 13 October 2025 | 10:00–11:30 UTC+1 Speakers: Michelle Clements (Chair, UK), Andrew Abaasa (Uganda), Philip Ayieko (Tanzania) and Vicky Simms (UK) Three Panel members working in Africa and the UK will be sharing their experiences of being trial statisticians, their challenges and top tips and having a discussion for the audience to join in.

The PHA Editors will consider any manuscript reporting original research on progress to achieving the SDGs. Suitable topics include infection-related topics such as vaccines, infection prevention control, outbreaks and antimicrobial resistance. Non-communicable diseases of public health importance include nutrition, the impact of climate change and planetary health. The journal aims to improve public health practice and we welcome operational research, lessons from implementation and evaluations of public health interventions. We will also consider submissions that focus on issues related to health care access and universal health coverage, quality, efficiency, cost-effectiveness, ethics and equity as well as education and training.